Table 3.
Lipid name | HIV+TB+ (n = 40) |
HIV−TB+ (n = 20) | ∗ P value | HIV+TST+ (n = 20) | HIV−TST+ (n = 20) | ‡ P value |
---|---|---|---|---|---|---|
TC | 88 (71.5–112) | 108 (87–130) | 0.012 | 106 (83–140) | 149 (140.5–162) | <0.001 |
TG | 76 (68–94) | 75 (66–84) | 0.200 | 80 (67–89) | 83.5 (73–110.5) | 0.315 |
LDL-C | 42 (32.45– 63.1) | 59.3 (46.9–73.2) | 0.008 | 54.2 (41–70.2) | 73.35 (63.8–87.2) | 0.004 |
HDL-C | 17.65 (12.35–22.65) | 26.5 (21.1–31.8) | <0.001 | 25.3 (18.1–37.6) | 42.4 (37.05– 49.3) | <0.001 |
Median (interquartile range) of lipid profile level values at baseline is shown. Comparison among the groups was determined using Wilcoxon Mann–Whitney test; ∗P value for the comparison between active TB groups with and without HIV; ‡P value for the comparison between latent TB groups with and without HIV.